Medical Devices Latin America

Latin America Microbiome Testing Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Latin America Microbiome Testing Market Industry Trends and Forecast to 2034: Segmented by (Sample, Use, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Latin America · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $38.3 Mn Placeholder estimate
Estimate 2025 $43.4 Mn 4.9% of the global market
Projected 2034 $131.3 Mn 202.8% Adds $87.9 Mn over 9 forecast years
CAGR 2025–2034 13.1% Faster than 79% of 173 Medical Devices markets here
Key players 5 Companies profiled
  • Latin America is 4.94% of the global market.
  • Among regions, the largest is North America at $431.1 Mn.
  • Fastest growing: Africa at 13.7% a year.
  • Latin America ranks 4th of 6 by size among regions.

Market size projection

Latin America

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$87.9 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Microbiome Testing Market market size by year, Latin America
YearMarket sizeChange that yearSince 2025
2024 (estimate) $38.3 Mn — —
2025 (base) $43.4 Mn +$5.0 Mn —
2026 (forecast) $49.0 Mn +$5.7 Mn +13.1%
2027 (forecast) $55.5 Mn +$6.4 Mn +27.9%
2028 (forecast) $62.7 Mn +$7.3 Mn +44.7%
2029 (forecast) $71.0 Mn +$8.2 Mn +63.6%
2030 (forecast) $80.2 Mn +$9.3 Mn +85.1%
2031 (forecast) $90.8 Mn +$10.5 Mn +109.3%
2032 (forecast) $102.7 Mn +$11.9 Mn +136.7%
2033 (forecast) $116.1 Mn +$13.4 Mn +167.7%
2034 (forecast) $131.3 Mn +$15.2 Mn +202.8%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $878.1 Mn
  2. North America $431.1 Mn
  3. US $300.9 Mn
  4. Europe $174.8 Mn
  5. APAC $167.8 Mn
  6. China $70.7 Mn
  7. Canada $60.0 Mn
  8. Japan $51.4 Mn
  9. Latin America (this report) $43.4 Mn
  10. Middle East $34.6 Mn
  11. Germany $26.7 Mn
  12. UK $24.4 Mn
  13. France $21.8 Mn
  14. Brazil $21.9 Mn
  15. Italy $19.8 Mn
  16. India $16.7 Mn
  17. Ecuador $15.8 Mn
  18. Saudi Arabia $15.8 Mn
  19. Spain $14.7 Mn
  20. Mexico $14.2 Mn
  21. Africa $14.1 Mn
  22. Australia $12.2 Mn
  23. New Zealand $7.8 Mn
  24. Russia $7.6 Mn
  25. South Africa $6.3 Mn
  26. UAE $4.1 Mn
  27. Egypt $2.5 Mn
  28. Philippines $1.8 Mn
  29. Hong Kong $1.5 Mn
  30. Malaysia $1.4 Mn
  31. Singapore $1.1 Mn
  32. Thailand $1.0 Mn
  33. Kenya $0.6 Mn

Report snapshot

Latin America Microbiome Testing Market Analysis at a glance
Market size, 2025$43.4 Mn placeholder estimate
Forecast, 2034$131.3 Mn placeholder estimate
Growth (CAGR), 2025–203413.1% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsSample, use and end user (see all)
Key playersViome, Thryve, Psomagen, Diversigen, Biomesight (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Latin America Microbiome Testing Market Analysis Executive Summary

Microbiome tests analyse the bacteria in stool or other samples to give insights into gut health and disease.

Key segments of the microbiome Testing market include sample (Stool, Skin and Oral) and use (Consumer Wellness, Clinical and Research).

Bar chart: Latin America Microbiome Testing market size, 2024–2034, placeholder estimates. $38.3 Mn in 2024, $43.4 Mn in 2025 and $131.3 Mn in 2034, 13.1% CAGR.
Latin America Microbiome Testing market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Latin America Microbiome Testing Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the microbiome Testing market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the microbiome Testing market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the microbiome Testing market.

Competitive Landscape for Microbiome Testing Market in Latin America

The microbiome Testing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Microbiome Testing Market in Latin America

Microbiome Testing in Latin America: rules and payment

In some of the countries we cover here, medical devices are regulated by ANVISA (Brazil)⁠[1], ARCSA (Ecuador)⁠[2] and COFEPRIS (Mexico)⁠[3]. How care is paid for in some of these countries: the SUS (Brazil)⁠[4]; public care and IESS (Ecuador)⁠[5]; and IMSS, ISSSTE and IMSS-Bienestar (Mexico)⁠[6].

[1] ANVISA. Checked 14 Nov 2026.

[2] ARCSA. Checked 14 Nov 2026.

[3] COFEPRIS. Checked 14 Nov 2026.

[4] CONITEC. Checked 14 Nov 2026.

[5] Ministry of Public Health of Ecuador. Checked 14 Nov 2026.

[6] Mexican Social Security Institute (IMSS). Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how microbiome Testing products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Latin America.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Microbiome Testing right now, from free public sources.

Latest research 49 papers since 2021 (worldwide)

  1. Microbiome testing in gastrointestinal cancers: From microbial signatures to clinical translation. Best practice & research. Clinical gastroenterology, 2026
  2. Oral versus vaginal Lactobacillus supplementation for endometrial dysbiosis: A paired pre and post-endometrial microbiome study. PloS one, 2026
  3. The Gut-Immune-Endometrial Axis in Reproductive Failure: a Structured Narrative Review of Intestinal Dysbiosis, Systemic Inflammation, and Chronic Endometritis. Reproductive sciences (Thousand Oaks, Calif.), 2026
  4. Seminal Microbiota and Pregnancy Outcomes: Mechanistic Insights, Clinical Implications, and Future Directions. Andrology, 2026
  5. Diagnostic Adjuncts and Biopsy Techniques for Oral Potentially Malignant Disorders and Oral Cavity Squamous Cell Carcinoma. Oral and maxillofacial surgery clinics of North America, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Microbiome Testing in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Microbiome Testing market in Latin America?
Placeholder estimate: about $43.4 Mn in 2025, rising to about $131.3 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Microbiome Testing market in Latin America growing?
Placeholder estimate: about 13.1% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Microbiome Testing market report cover?
The report splits the market by sample (Stool, Skin, Oral, Vaginal), use (Consumer Wellness, Clinical, Research) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Microbiome Testing market?
Key players include Viome, Thryve, Psomagen, Diversigen and Biomesight.
What is driving the Microbiome Testing market?
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the microbiome Testing market.
How much research is published on Microbiome Testing?
PubMed lists 49 papers on Microbiome Testing added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Microbiome Testing in Latin America? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Prebiotics: Feeding the Good BacteriaMore than 90% of US women and 97% of men do not eat enough fibre. Prebiotics are the fibres that feed helpful… Gut Health and Probiotics: What the Science SaysGut health is one of the biggest wellness trends. Probiotics help in some cases, but not all products or… Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
Back to Catalogue
Keep exploring

Related Medical Devices reports in Latin America

See all
Same topic, other categories

Related on diagnostics and lab testing and gut health

See the topic